High SARS-CoV-2 Seroprevalence But No Severe Course of COVID-19 Disease Among People on Opioid Agonist Treatment in Zurich: a Cross-Sectional Study. Swiss Med Wkly 2022, 152 (0102), w30122. https://doi.org/10.4414/SMW.2022.w30122.